Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-Klotho (α-Klotho) is a transmembrane protein with a secreted soluble form, playing crucial roles in mineral metabolism, aging, and cellular protection. As a co-receptor for FGF23, it regulates phosphate and vitamin D metabolism in the kidneys. Its deficiency is linked to premature aging and kidney disease, making it a potential therapeutic target.
Acts as a co-receptor for FGF23, modulating downstream signaling pathways involved in phosphate regulation, vitamin D metabolism, and other cellular processes. Soluble form interacts with FGFRs and TGF-beta receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-Klotho (α-Klotho).